Effects of Ultrasound-guide Hypertonic Dextrose Injection for Chronic Subacromial Bursitis
Unknown statusNot applicableNCT04916353
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to investigate the echoguide hypertonic injection and compared steroid injection in subacromial bursitis patients about clinical and ultrasound image presentation.
Study details
- Official title
- Effects of Ultrasound-guide Hypertonic Dextrose Injection for Chronic Subacromial Bursitis
- Conditions
- Interventions
- Drug: hypertonic dextrose water
- Drug: Triamcinolone Acetonide.
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Start date
- 2021-06-10
- Primary completion
- 2021-11-30
- Sex
- All
- Age range
- from 20 Years
- Results posted
- No results posted in this snapshot
- Countries
- Taiwan
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Aged more than 20 years old with diagnosis of chronic supraspinatus tendinosis by ultrasound and clinical shoulder pain lasting for more than 3 months. Exclusion Criteria: * History of shoulder fracture and operation, with frozen shoulder or full thickness ruptur of rotator cuff, steroid, or hyaluronic acid, or platelet rich plasma (PRP) injection during the period of intervention and following up.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04916353